Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Gilead Sciences Inc. (GILD) shares rose 2.15% to $149.37 on a weak trading day for the market, marking its fifth consecutive gain and a new 52-week high. In contrast, the S&P 500 fell 1.23% and the Dow Jones dropped 1.20%. Gilead outperformed competitors like Johnson & Johnson, which rose 1.42%, while Pfizer fell 1.08% and Abbott rose 0.81%. Trading volume reached 9.1 million, exceeding the 50-day average of 7.2 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments